💉 New technology called Quantitative Trait Loci (QTL) enables the creation of more affordable and effective vaccines.
🦠 Virus-like particles (VLPs) are the current source of animal vaccines but can be expensive and challenging to manufacture.
💰 Lower manufacturing costs mean more vaccines can be developed, benefiting farmers, consumers, and livestock.
🔬 QTL technology allows for the customisation of manufacturing strains to produce challenging VLPs efficiently.
🚀 This breakthrough opens up opportunities for better and cheaper animal vaccines to protect food supply chains.
Introduction:
The article discusses the challenges and limitations of manufacturing animal vaccines and the potential of new genomic technology to reduce costs and improve access to vaccines. Animal vaccines are essential for protecting livestock and preventing the spread of viruses in the food supply chain. However, high manufacturing costs and technical difficulties hinder the development of new vaccines.
- The high costs of commercial-scale manufacturing and technical difficulties limit the number of animal vaccines being developed.
- Virus-like particles (VLPs) are currently a principal source of animal vaccines but are technically complicated and expensive to manufacture.
- New technology, called Quantitative Trait Loci (QTL) technology, has the potential to create a broader range of VLP vaccines that were previously challenging to make.
- QTL technology can develop manufacturing strains that secrete technically challenging VLPs and optimize downstream processing, reducing overall manufacturing costs.
- This technology provides an opportunity to bring new and more affordable vaccine products to the market, benefiting farmers, consumers, and livestock.
Conclusion:
New genomic technology, such as QTL technology, holds promise in reducing the manufacturing costs of animal vaccines. By developing manufacturing strains that secrete technically challenging VLPs and optimizing downstream processing, this technology can bring new and more affordable vaccine products to the market. This has the potential to benefit farmers, consumers, and livestock by improving access to effective vaccines and safeguarding food supply chains.
